Page last updated: 2024-09-04

irofulven and Retinal Diseases

irofulven has been researched along with Retinal Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fitzsimmons, TD; Hammond, LA; Harrison, JM; Melendez, RF; Rowinsky, EK	1
Gupta, N; Lee, MS; Loewenstein, J; Milam, AH; Penson, RT; Seiden, MV; Wepner, MS	1

Trials

1 trial(s) available for irofulven and Retinal Diseases

Article	Year
Cone damage in patients receiving high-dose irofulven treatment. Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Electroretinography; Female; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Humans; Middle Aged; Neoplasms; Retinal Cone Photoreceptor Cells; Retinal Diseases; Rhodopsin; Sesquiterpenes; Visual Field Tests; Visual Fields	2005

Article

Year

Cone damage in patients receiving high-dose irofulven treatment.

Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:1

Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Electroretinography; Female; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Humans; Middle Aged; Neoplasms; Retinal Cone Photoreceptor Cells; Retinal Diseases; Rhodopsin; Sesquiterpenes; Visual Field Tests; Visual Fields

2005

Other Studies

1 other study(ies) available for irofulven and Retinal Diseases

Article	Year
Acute retinal toxicity from the novel anti-tumor agent, Irofulven. Documenta ophthalmologica. Advances in ophthalmology, 2004, Volume: 108, Issue:3 Topics: Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Electroretinography; Evoked Potentials, Visual; Female; Humans; Middle Aged; Retina; Retinal Diseases; Sesquiterpenes; Visual Fields	2004